Nuklearmediziner*innen sollten mit Normvarianten in der Bildgebung und häufigen Pitfalls, die zu Fehlinterpretationen und damit zu potenziellen Änderungen des Managements bei Patienten mit Hodgkin und Non-Hodgkin-Lymphomen führen könnten, vertraut sein. In diesem Artikel geben wir einen Überblick über häufig auftretende Pitfalls in der [18F]FDG PET/CT bei Lymphomen sowie über seltene Ursachen für Fehlbefunde und deren Interpretation.
Abstract
Malignant lymphoma is a quite common malignancy affecting all age groups. The usefulness of positron emission tomography/computed tomography using 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG PET/CT) has already been widely established in the assessment of Hodgkin lymphoma and many forms of non-Hodgkin lymphoma. However, many factors such as histopathological characteristics and previous and ongoing therapies may affect the [18F]FDG uptake in various organs. Furthermore, nuclear medicine physicians should be familiar with imaging variants and atypical findings as well as common pitfalls, which may cause misinterpretation and might lead to inappropriate management of the disease. In this article we review common pitfalls and variants of [18F]FDG PET/CT imaging in lymphoma and present cases with atypical findings with recommendations on accurate interpretation.
Schlüsselwörter
Lymphom - [
18F]FDG, PET/CT - Pitfalls - onkologische Diagnostik
Keywords
lymphoma - [
18F]FDG, PET/CT - pitfalls - oncological diagnostics